Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization

BACKGROUND: Transarterial chemoembolization (TACE) is recommended for patients with intermediate hepatocellular carcinoma (HCC) according to treatment guidelines. However, a large number of patients with advanced HCC also receive TACE in clinical practice, especially for those with liver-confined HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhe-Xuan, Li, Jing, Wang, En-Xin, Xia, Dong-Dong, Bai, Wei, Wang, Qiu-He, Yuan, Jie, Li, Xiao-Mei, Niu, Jing, Yin, Zhan-Xin, Xia, Jie-Lai, Fan, Dai-Ming, Han, Guo-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183869/
https://www.ncbi.nlm.nih.gov/pubmed/32351295
http://dx.doi.org/10.3748/wjg.v26.i15.1805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183869/
https://www.ncbi.nlm.nih.gov/pubmed/32351295
http://dx.doi.org/10.3748/wjg.v26.i15.1805

Ejemplares similares